Survival benefit of metastasectomy for Krukenberg tumors from gastric cancer

Gynecologic Oncology

Volumn 94, Issue 2, 2004, Pages 477-482

  Cheong, Jae Ho ^a   Hyung, Woo Jin ^a   Chen, Jian ^a   Kim, Junuk ^a   Choi, Seung Ho ^a   Noh, Sung Hoon ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

Gastric cancer; Krukenberg tumor; Metastasectomy; Prognosis

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADULT; AGED; ARTICLE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; DISEASE DURATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; OVARY CARCINOMA; PRIORITY JOURNAL; STOMACH CARCINOMA; STOMACH SURGERY;

ADULT; AGED; FEMALE; HUMANS; KRUKENBERG TUMOR; MIDDLE AGED; OVARIAN NEOPLASMS; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS; TREATMENT OUTCOME;

EID: 3543123544     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ygyno.2004.05.007     Document Type: Article

References (29)

1. Petru E., Pickel H., Heydarfadai M., Lahousen M., Haas J., Schaider H., et al. Nongenital cancers metastases to the ovary. Gynecol. Oncol. 44:1992;83-86
2. Hale R.W. Krukenberg tumors of the ovaries: a review of 81 records. Obstet. Gynecol. 32:1968;221-225
3. Holtz F., Hart W.R. Krukenberg tumors of the ovary: a clinicopathologic analysis of 27 cases. Cancer. 50:1982;2438-2447
4. Woodruff J.D., Novak E.R. The Krukenberg tumors, study of 48 cases from the ovarian registry. Obstet. Gynecol. 15:1960;351-360
5. Sugarbaker P.H., Averbach A.M. Krukenberg syndrome as a natural manifestation of tumor cell entrapment. Cancer Treat. Res. 82:1996;163-191
6. Kang S.B., Park N.H., Choi Y.M., Lee H.P. Krukenberg tumors of the ovary: a clinical analysis of 16 cases. J. Korean Cancer Assoc. 22:1990;194-201
7. Siewert J.R., Bottcher K., Roder J.D., Busch R., Hermanek P., Meyer H.J. Prognostic relevance of systematic lymph node dissection in gastric carcinoma. German Gastric Carcinoma Study Group. Br. J. Surg. 80:1993;1015-1018
8. Inokuchi K. Prolonged survival of stomach cancer patients after extensive surgery and adjuvant treatment: an overview of the Japanese experience. Semin. Surg. Oncol. 7:1991;333-338
9. Maruyama K., Okabayashi K., Kinoshita T. Progress in gastric cancer surgery in Japan and its limits of radicality. World J. Surg. 11:1987;418-425
10. Yoo C.H., Noh S.H., Shin D.W., Choi S.H., Min J.S. Recurrence following curative resection for gastric carcinoma. Br. J. Surg. 87:2000;236-242
11. Duarte I., Llanos O. Patterns of metastases in intestinal and diffuse types of carcinoma of the stomach. Hum. Pathol. 12:1981;237-242
12. Tamura P.Y., Curtiss C. Carcinoma of the stomach in the young adults. Cancer. 13:1960;379-385
13. Saphir O. Signet-ring carcinoma. Mil. Surg. 109:1951;360-366
14. Novak E., Gray L.A. Krukenberg tumors of the ovary. Clinical and pathological study of 21 cases. Surg. Gynecol. Obstet. 66:1938;157-167
15. Japanese Research Society for Gastric Cancer The general rules for the gastric cancer study in surgery and pathology. Jpn. J. Surg. 11:1981;127-139
16. Sobin L.H., Wittekind C. International Union Against Cancer (UICC) TNM classification of malignant tumors. fifth ed.:1997;59-62 Wiley-Liss, New York
17. Norusis M.J. SPSS 9.0 Guide to Data Analysis. 1998;Prentice Hall, Englewood Cliffs (NJ)
18. Webb M.J., Decker D.G., Mussey E. Cancer metastatic to the ovary: factors influencing survival. Obstet. Gynecol. 45:1975;391-396
19. Mazur M.T., Hsueh S., Gersell D.J. Metastases to the female genital tract. Cancer. 53:1984;1978-1984
20. Eisenkkop S.M., Friedman R.L., Wang H.J. Complete cytoreductive surgery is feasible and maximize survival in patients with advanced epithelial ovarian cancer: a prospective study. Gynecol. Oncol. 69:1998;103-108
21. Zang R.Y., Zang Z.Y., Li Z.T., Chen J., Tang M.Q., Liu Q., et al. Effect of cytoreductive surgery on survival of patients with recurrent epithelial ovarian cancer. J. Surg. Oncol. 75:2000;24-30
22. Rayson D., Bouttel E., Whiston F., Stitt L. Outcome after ovarian/adnexal metastectomy in metastatic colorectal carcinoma. J. Surg. Oncol. 75:2000;186-192
23. McGill F.M., Ritter D.B., Rickard C.S., Kaleya R.N., Wadler S., Greston W.M., et al. Krukenberg tumors: can management be improved? Gynecol. Obstet. Invest. 48:1999;61-65
24. Ohsako M., Sakoda K., Tabata M., Mizouchi J., Sakamoto H., Yamaguchi A., et al. A case of advanced gastric cancer surviving 3 years and 6 months after resection of Krukenberg tumor. Jpn. J. Cancer Chemother. 21:1994;873-876
25. Noh S.H., Yoo C.H., Chung H.C., Roh J.K., Shin D.W., Min J.S. Early postoperative intraperitoneal chemotherapy with mitomycin C, 5-fluorouracil and cisplatin for advanced gastric cancer. Oncology. 60:2001;24-30
26. Hagiwara A., Takahashi T., Kojima O., Sawai K., Yamaguchi T., Yamane T., et al. Prophylaxis with carbon-adsorbed mitomycin against peritoneal recurrence of gastric cancer. Lancet. 339:1992;629-631
27. Yonemura Y., Fujimura T., Fushida S., Takegawa S., Kamata T., Katayama K., et al. Hyperthermo-chemotherapy combined with cytoreductive surgery for the treatment of gastric cancer with peritoneal dissemination. World J. Surg. 15:1991;530-536
28. Hamazoe R., Maeta M., Kaibara N. Intraperitoneal thermochemotherapy for prevention of peritoneal recurrence of gastric cancer. Final results of a randomized controlled study. Cancer. 73:1994;2048-2052
29. Yu W., Whang I., Suh I., Averbach A., Chang D., Sugarbaker P.H. Prospective randomized trial of early postoperative intraperitoneal chemotherapy as an adjuvant to resectable gastric cancer. Ann. Surg. 228:1998;347-354